CoChat

Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5

Open access
Heinbockel, Lena, Weindl, Günther, Martinez-de-Tejada, Guillermo, Correa, Wilmar, Sanchez-Gomez, Susana, Bárcena-Varela, Sergio, Goldmann, Torsten, Garidel, Patrick, Gutsmann, Thomas, Brandenburg, Klaus · 2018 · Frontiers in Immunology
Cited by 74

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The most potent cell wall-derived inflammatory toxins (‘pathogenicity factors’) of Gram-negative and –positive bacteria are lipopolysaccharides (LPS, endotoxins) and lipoproteins (LP), respectively. Despite the fact that the former signals via Toll-like receptor 4 (TLR4) and the latter via TLR2, the physico-chemistry of these compounds exhibits considerable similarity, an amphiphilic molecule with a polar and charged backbone and a lipid moiety. While the exterior portion of the LPS (i.e. the O-chain) represents the serologically relevant structure, the inner part, the lipid A, is responsible for one of the strongest inflammatory activities known. In the last years, we have demonstrated that antimicrobial peptides from the Pep19-2.5 family, which were designed to bind to LPS and LP, act as anti-inflammatory agents against sepsis and endotoxic shock caused by severe bacterial infections. We also showed that this anti-inflammatory activity requires specific interactions of the peptides with LPS and LP leading to exothermic reactions with saturation characteristics in calorimetry assays. Parallel to this, peptide-mediated neutralization of LPS and LP involves changes in various physical parameters, including both the gel to liquid crystalline phase transition of the acyl chains and the three-dimensional aggregate structures of the toxins. Furthermore, the effectivity of neutralization of pathogenicity factors by peptides was demonstrated in several in vivo models together with the finding that a peptide based therapy sensitizes bacteria (also antimicrobial resistant) to antibiotics. Finally, a significant step in the understanding of the broad anti-inflammatory function of Pep19-2.5 was the demonstration that this compound is able to block the intracellular endotoxin signaling cascade.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2018.01704

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 74

Metadata

Authors
Heinbockel, L., Weindl, G., Martinez-de-Tejada, G., Correa, W., Sanchez-Gomez, S., Bárcena-Varela, S., Goldmann, T., Garidel, P., Gutsmann, T., & Brandenburg, K.
Venue
Frontiers in Immunology
Published
2018-07-26
Volume
9
Pages
1704-1704
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2883186768
Cited by
74
References
2
FWCI
4.32
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5. https://app.cochat.ai/papers/10.3389/fimmu.2018.01704
The paper
Heinbockel, L., Weindl, G., Martinez-de-Tejada, G., Correa, W., Sanchez-Gomez, S., Bárcena-Varela, S., Goldmann, T., Garidel, P., Gutsmann, T., & Brandenburg, K. (2018). Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2018.01704

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.